Abstract
AbstractBackgroundAmyloid PET VR is the most common method to determine Aβ pathology in clinical practice. Amyloid positivity by VR or CL cut‐off generally shows a good concordance, however, it is possible to have discordant cases whereby the VR is positive, but CL is below the cut‐off of amyloid positivity, or vice versa. The objective of this analysis was to assess the rate and cause of discordance in defining amyloid pathology using VR and CL in Eisai’s Elenbecestat MissionAD Phase 3 program.MethodFlorbetaben, Florbetapir, and Flutemetamol amyloid PET scans from 3412 participants with MCI due to AD or mild AD dementia were visually read at screening by trained neuroradiologists and quantitated using CLs. VR classification of the amyloid status is based on the higher or equal grey matter (GM) uptake relative to uptake in the white matter (WM) in at least one area, as per manufacturer’s guidance. Quantitatively, amyloid negativity was defined as CL<30. The number of positive cortical regions (SUVR>1.17) was also calculated.ResultThe positivity concordance between VR and CL was 92%, while the negativity concordance was 94.6%. VR+/CL‐ discordance was 8% (n = 1814 VR+, n = 145 CL‐) whereas VR‐/CL+ discordance was 5.4% (n = 1598 VR‐, n = 86 CL+). VR+/CL‐ discordant cases had significantly fewer positive cortical regions than both VR+/CL+ and VR‐/CL+ cases (Figure 1). VR‐/CL+ had a significantly higher WM uptake than both VR‐/CL‐ and VR+/CL‐ cases (Figure 2).ConclusionVR+/CL‐ discordant cases show fewer amyloid positive cortical regions, computing CLs results in below cut‐off values due to a dilution effect. These cases are considered VR+ as per manufacturer’s guidelines as they show at least one area of amyloid accumulation. On the other hand, VR‐/CL+ discordant cases result from an increased WM uptake, reducing GM/WM contrast required to determine visual read positivity. VR represents a robust and validated method to determine the presence of amyloid deposition and enables enrolling patients with amyloid beta pathology, as visible on amyloid PET scans, while CLs are optimal for assessing longitudinal changes over time and are a more sensitive measure to assess disease progression.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.